The task of developing ESC Guidelines covers not only the integration of the most recent
research, but also the creation of educational tools and implementation programmes for the …

The incidence of chronic thromboembolic pulmonary hypertension (CTEPH) after pulmonary
embolism (PE) is relevant for management decisions but is currently unknown. We …

Background— Right ventricular failure is a leading cause of death in patients with chronic
pulmonary hypertension (PH). We checked whether detection of cardiac troponin T (cTnT), a …

Aims Despite growing interest in biomarkers application for risk evaluation in acute pulmonary
embolism (APE), no decision-making levels have been defined. Methods and results We …

The optimal N-terminal pro-brain natriuretic peptide (NT-proBNP) cut-off value for risk
stratification of pulmonary embolism remains controversial. In this study we validated and …

determination and the implementation of preventive, diagnostic or therapeutic medical
strategies. However, the ESC Guidelines do not override in any way whatsoever the individual …

… Piotr Pruszczyk , Piotr Pruszczyk … Authors/Task Force Members, Adam Torbicki, Arnaud
Perrier, Stavros Konstantinides, Giancarlo Agnelli, Nazzareno Galiè, Piotr Pruszczyk, Frank …

Background The role of fibrinolytic therapy in patients with intermediate-risk pulmonary
embolism is controversial. Methods In a randomized, double-blind trial, we compared …

Study objectives Baseline prognostic assessment in patients with pulmonary hypertension (PH)
may help in the selection of treatment. High plasma levels of natriuretic peptide type B …

Background— The new, high-sensitivity troponin T (hsTnT) assay may improve risk stratification
of normotensive patients with acute pulmonary embolism (PE). We externally validated …